Recomienda este artículo a tus amigos:
TRAIL Fas Ligand TNF and TLR3 in Cancer 1st ed. 2017 edition
TRAIL Fas Ligand TNF and TLR3 in Cancer
Death receptors, including TRAIL-R1, TRAIL-R2, Fas and TNF-RI, owing to their ability to trigger apoptosis and to contribute to the elimination of cancer cells by the immune system have been considered, to variable extent, as important therapeutic targets for cancer therapy.
317 pages, 35 Illustrations, color; 5 Illustrations, black and white; XIII, 317 p. 40 illus., 35 ill
| Medios de comunicación | Libros Book |
| Publicado | 10 de julio de 2017 |
| ISBN13 | 9783319568041 |
| Editores | Springer International Publishing AG |
| Páginas | 317 |
| Dimensiones | 150 × 220 × 20 mm · 639 g |
| Lengua | Alemán |
| Editor | Micheau, Olivier |